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RESUMO
Objetivos: Estudar os resultados da cirurgia da catarata induzida pela radioterapia para 
o tratamento do retinoblastoma em crianças. 
Métodos: Estudo retrospectivo intervencional em série de casos onde seis pacientes conse-
cutivos apresentaram catarata secundária à terapia por radiação para o retinoblastoma. 
Intervenção: Facoemulsificação e implante de lente intraocular acrílica dobrável. Foram 
avaliadas: acuidade visual, oftalmoscopia binocular indireta e biomicroscopia. Material 
para análise histológica do cristalino e do humor aquoso foi coletado durante as cirurgias. 
Resultados: Seis crianças, entre 3 e 5 anos de idade, com catarata secundária à radiação 
para tratamento de retinoblastoma foram submetidas à cirurgia de facoemulsificação 
com implante de lente intraocular. A média do intervalo de tempo decorrido entre a 
radioterapia e o diagnóstico da catarata foi 22,3 meses. O período médio de seguimento 
após a cirurgia foi de 17,2 meses (intervalo: 12 a 23 meses). Todos os olhos melhoraram a 
visão e mantiveram eixo visual livre permitindo a fundoscopia para monitorar o tumor. 
Nenhum paciente evoluiu com recorrência ou disseminação do retinoblastoma. A análise 
histopatológica do material colhido resultou em ausência de células tumorais nas amostras. 
Conclusões: A cirurgia de facoemulsificação com implante de lente intraocular acrílica 
dobrável mostrou ser um procedimento seguro e efetivo para o tratamento da catarata 
induzida pela radioterapia em pacientes portadores de retinoblastoma.
Descritores: Retinoblastoma/cirurgia; Retinoblastoma/radioterapia; Neoplasisas da 
retina/radioterapia; Catarata/etiologia; Enucleação ocular; Lesões por radiação; Radio-
terapia/efeitos adversos; Implante de lente intraocular; Humanos; Criança
ABSTRACT
Purpose: To study the results of cataract surgery in children with radiation-induced 
cataract after treatment for retinoblastoma.
Methods: Retrospective interventional case series. Six consecutive patients diagnosed 
with secondary cataracts due to radiation therapy for retinoblastoma. Intervention: Pha -
coemulsification and foldable acrylic intraocular lens implantation. Outcomes  mea su- 
 red: Visual acuity, binocular indirect ophthalmoscopy and slit-lamp biomicroscopy. 
Aspirated lens material and aqueous humor samples were collected during surgery. 
Results: Six uniocular children between 3 to 5 years of age at time of surgery were 
studied. The mean time interval between radiotherapy and cataract diagnosis was 
22.3 months. The mean follow-up after surgery was 17.2 months (range: 12 to 23 
months). All eyes achieved a clear visual axis after surgery allowing monitoring of 
the tumor status. None developed recurrence or retinoblastoma dissemination. 
His topathological analysis of the aspired material showed no tumoral cells in all 
sam ples. All patients improved vision after cataract surgery. 
Conclusions: Phacoemulsification with acrylic intraocular lens implantation seems to 
be a safe, feasible, and effective method for the removal of radiation-induced cataracts 
in patients with treated retinoblastoma.
Keywords: Retinoblastoma/cirurgia; Retinoblastoma/radiotherapy; Retinal neo- 
plasms/radiotherapy; Cataract/etiology; Eye enucleation; Radiation injuries; Radio-
therapy/adverse; Lens implantation, intraocular; Humans; Child
INTRODUCTION
Retinoblastoma (RB) is the most common intraocular malignancy 
in childhood, occurring in approximately 1 of 20,000 live births(1).
The goals of management of RB are, first, to preserve life and, se-
cond, to salvage the eye and restore vision if possible(2). Earlier diagnosis 
coupled with new therapeutic modalities such as External Beam Radio-
therapy (EBRT), radioactive plaque and brachytherapy have allowed 
successful treatment avoiding enucleation in many cases(1-5). 
About 20% to 87% of the patients treated with radiotherapy can 
develop a radiation-induced secondary cataract blocking the visual 
axis and therefore causing severe reduction of visual acuity (VA)(6-8).
Maintenance of a clear visual axis is important in order to allow 
the examination of the eye fundus and to observe the regressed re -
tinoblastoma lesions(9).
The purpose of this study was to evaluate the visual outcome and 
ocular complications of the cataract surgery by phacoemulsification 
and foldable acrylic intraocular lens implantation (IOL) in children 
with radiation-induced cataract after treatment for RB. 
METHODS
Six uniocular patients with secondary cataract due to radiation 
therapy for RB treatment were submitted to phacoemulsification 
and IOL implantation at the Congenital Cataract Section, Department 
of Ophthalmology, Federal University of Sao Paulo SP, Brazil. During 
surgery, a sample of aqueous humor (0.2 ml) was collected from the 
anterior chamber for analysis. Aspirated lens material (0.2 ml) was also 
sent for histopathological analysis.
Table 1 presents the age (in months) of patients at RB diagnosis, 
the different prescribed treatments, and the time interval between 
radiotherapy and the diagnosis of cataract. All patients had bilateral 
RB, and all of them had one eye previously enucleated. All eyes had 
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inactive tumors when they presented for cataract surgery. Lens opa -
cities hindered fundus examination in all patients. 
Visual acuity was measured with Snellen acuity cards, Teller Acuity 
Cards or Lea Hyvarigen Acuity Cards depending on patient collabo-
ration. Final best corrected visual acuity (BCVA) was obtained at the 
last followup visit.
Calculation of the IOL power was based on previous studies of 
axial length growth in pseudophakic eyes of children with lamellar 
cataract, as follows: children aged 3 to 4 years had a 10% reduction 
of the calculated IOL power. Children between 4 and 6 years had an 
addition of 0.75% on the preoperative axial length in order to calcu-
late the final IOL diopter(10).
The same surgeon (MBT) operated on all cases using the same 
technique. A clear corneal tunnel incision was performed and a lateral 
paracentesis was used to allow the introduction of any additional ins-
trument during phacoemulsification. Viscoelastic substance (Viscoat®) 
was used to fill the anterior chamber. An anterior continuous circular 
capsulorhexis followed by hydrodissection and hydrodeliniation were 
performed. Phacoemulsification or phacoaspiration of the lens was 
performed followed by a meticulous aspiration of lens material. A 
foldable acrylic IOL (AcrySof®) was implanted within the capsular bag. 
Next step included aspiration of the viscoelastic substance from the 
anterior chamber and injection of a miotic drug (Miostat®). One or two 
single sutures (mononylon 10-0) were used to achieve a safe closure of 
the corneal incision. Subconjuntival dexamethasone (0.5 mg/1 ml) and 
gentamicin (40 mg/1 ml) were injected at the end of surgery. Topical 
antibiotics and corticosteroids were applied for the first two weeks 
after surgery and tapered during 2 months of follow-up.
Visual acuity, binocular indirect ophthalmoscopy and slit lamp 
examination were assessed on all postoperative visits.
RESULTS
Patients were between 3 and 5 years-old (mean 4.9 years-old) at 
the time of cataract surgery. Three eyes presented nuclear cataract 
and three eyes presented posterior sub-capsular cataract. Mean time 
between radiotherapy and cataract diagnosis was 22.3 months. All 
patients included in this study showed initial VA worse than 20/200. 
All children improved VA after surgery (Table 2). Mean postoperative 
follow-up was 17.2 months (12 to 23 months).
A posterior paracentral capsule opacification (PCO) was observed 
during surgery in three eyes (patients #2, #4 and #5) but the capsule 
was left intact. No patient needed a Neodimium YAG laser posterior 
capsulotomy. 
Patient #4 presented an inflammatory membrane anterior to the 
IOL that disappeared within two weeks after surgery.
One eye (patient #3) developed a paracentral mild PCO during 
the follow-up. This PCO did not affect VA or eye fundus examination 
(Figure 2).
Five eyes received a three-piece acrylic hydrophobic foldable IOL 
(MA60AC, Alcon AcrySof®) and one eye received a single-piece IOL 
(SA30AL Alcon AcrySof®).
Intraocular lens power ranged from +21 to +29 (mean +25.5 D). 
Refraction was obtained and glasses with protective polycarbonate 
multifocal lenses were prescribed for all patients.
Slit lamp examination postoperatively showed severe dry eye 
with fluorescein staining in two eyes. 
All eyes achieved a clear visual axis after cataract surgery, allowing 
monitoring tumoral status (Figure 1, patient #6). None had recurrence 
or spread of the tumor during the follow-up time of this study. Histo-
pathological analysis of aqueous humor and aspirated lens material 
showed no tumoral cells in the samples of all patients.
DISCUSSION
Retinoblastoma is the most frequent intraocular tumor in child hood(1) 
and early detection and treatment is essential. Erwenne and Franco(11) 
found that advanced age and delayed diagnosis increase the chance 
for extraocular disease that mandates significantly more aggressive 
treatment. 
Time range between the appearance of first RB signs and the 
initial treatment as well as the management of RB influence the out-
comes(4).
In the past, standard treatments for RB consisted of enuclea-
tion and EBRT. Systemic chemotherapy was generally reserved for 
patients with invasion of the optic nerve, choroid, orbit or with me-
tastatic disease(1). Nowadays, chemoreduction has been widely used 
to avoid EBRT(1,5). Other management options in children include ra-
Table 1. Retinoblastoma diagnosis, therapy and time interval between 
radiotherapy and cataract development
Patient Age* TTT Cryo Photo Brachy Chemo RXT Cataract†
1 10 + + + 0 + + 14
2 04 0 0 + 0 0 + 40
3 02 + + + 0 + + 25
4 02 + + + + 0 + 14
5 22 + 0 + 0 + + 14
6 20 + 0 0 + 0 + 24
*= age in months at retinoblastoma diagnosis; TTT= transpupillary thermotherapy; Cryo= 
cryotherapy; Photo= phototherapy; Brachy= brachytherapy; Chemo= chemotherapy; 
RXT= radiotherapy; += therapy yes; 0= therapy no; †= time interval between radiotherapy 
and radiation-induced cataract (in months).










1 3 20/570 23 20/400
2 5 20/200 12 20/30
3 4 CF 2 m 19 20/70
4 4 CF 50 cm 13 20/200
5 5 LP 16 20/60
6 5 LP 20 20/40
VA= visual acuity; Final BCVA= best corrected VA at last follow-up; CF= counting fingers 
vision; LP= light perception vision.
Figure 1. Patient # 6 - Eye fundus with inactive retinoblastoma: tumor status 20 months 
after cataract surgery and IOL implantation. 
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diation therapy, photocoagulation, cryotherapy, and chemotherapy. 
Focal treatment modalities, as radioactive plaques, have promising 
prospects(4,9). 
Radiotherapy has been a useful modality in the treatment of RB, 
but lens irradiation may cause cataract induction, usually occurring 2 
to 12 years after treatment(12). In our study we found a mean latency 
period of 22.3 months from radiotherapy to cataract diagnosis. 
Treatment of radiation-induced cataracts is similar to treatment 
for pediatric cataracts. The implantation of an IOL by itself may not 
increase the risk of recurrence of RB or systemic metastasis and could 
be considered for providing optimal visual rehabilitation after cata-
ract surgery. All patients in this series improved VA, although other 
factors as tumor size and location, age of the patient and amblyopia 
may influence the final visual results. 
Samples of aqueous humor and aspirated lens material were 
easily obtained during cataract surgery. Hadjistilianou et al., analyzed 
aqueous humor proteins in patients with RB and reported an increase 
in protein content in eyes with RB(13). In order to investigate malignant 
cells, the samples were collected and a histopathological analysis was 
performed. The results of our study showed the absence of malignant 
cells in the samples. 
The role of posterior capsulotomy in spreading tumor cells is yet 
unknown but Brooks et al.(3), recommended avoiding posterior capsu-
lotomy to prevent an eventual seeding of the tumor. Although poste-
rior capsulorrhexis in children is advisable, we preferred to main tain 
the posterior capsule in order to respect the anatomical barrier between 
anterior and posterior eye segments. All children were older than 3 
years-age at the time of surgery and might be able to collaborate to 
perform Neodimiun- YAG laser posterior capsulotomy if necessary.  
Miller et al.(14), described good results after pars plana lensectomy 
and IOL implantation in radiation-induced cataracts in children with RB. 
Same authors(15) reported a series of eleven eyes that underwent 
a primary IOL implantation after RB treatment. They concluded that 
IOL implantation seemed to be a safe method for aphakia correction. 
The authors advised penetrating the anterior chamber through a 
clear corneal incision to avoid direct contact with conjunctival blood 
vessels, scleral tissues, and vitreous management in order to reduce 
the risk of spreading tumoral cells(15).
Besides tumoral spread or recurrences, the complications ex-
pected in the removal of radiation-induced cataracts are similar to 
pediatric cataract surgery(3,9,16-17). In this case series no complications 
related to the RB occurred. All eyes studied did not develop tumor 
recurrence or dissemination during the follow-up period. Attention 
to dry eye signs and symptoms is a must in those irradiated eyes. 
Artificial tear drops and ointments were prescribed to two patients 
diagnosed with dry eye.
In three eyes a partial PCO was detected at the end of surgery, but 
posterior capsulotomy was not performed due to the risk of tumor 
dissemination. Despite the capsular opacification, indirect ophthal-
moscopy was feasible and VA improved after surgery. Maintenance 
of a clear visual axis was obtained, allowing adequate view of the 
posterior pole in order to monitor the regressed tumoral lesions.
Intraocular lenses choice was important, IOL material and model 
are related to biocompatibility in adults(18,19) and children(20-22). This 
study showed good results with acrylic hydrophobic IOLs.
Refractive results were within the expected calculated diopters. 
Future changes in refraction may occur in these growing eyes. IOL 
power calculation was based on previous data on axial lengths in 
children with cataracts(10). There are no studies of ocular growth in 
eyes with RB and cataracts. Predictive IOL power calculation and axial 
growth in eyes with RB need further investigation.
Hoehn et al.(23), showed the effectiveness of cataract surgery to 
improve quality of life in affected children. The children in our study 
were all uniocular patients and achieved an improvement of vision 
that could lead to better ambulation and better integration in the 
community and school. 
CONCLUSION
No tumor spread or recurrences were observed in this series and 
improvement of VA was obtained in all patients. We conclude that 
although the long term risk-benefit is still unknown, phacoemulsifi-
cation and foldable acrylic IOL implantation in eyes with previously 
treated RB seems to be a feasible, safe and effective treatment for 
radiation-induced cataracts, but the number of included patients is 
too low in order to establish an outcome complication profile.
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